mitapivat

CHEBI:CHEBI_750988

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
2594795
generic_name
mitapivat
dosage_form
TABLET, FILM COATED
product_type
HUMAN PRESCRIPTION DRUG
marketing_category
NDA
listing_expiration_date
20251231
route
ORAL
active_ingredient_strength
20 mg/1
pharm_class_moa
UGT1A1 Inducers [MoA]
pharm_class
UGT1A1 Inducers [MoA]
nui
N0000194036
marketing_start_date
20220218
package_marketing_start_date
20220218
brand_name
Pyrukynd
brand_name_base
Pyrukynd
product_ndc
71334-215
application_number
NDA216196
labeler_name
Agios Pharmaceuticals, Inc.
manufacturer_name
Agios Pharmaceuticals, Inc.
spl_id
2499af83-3fab-0169-e063-6294a90ada38
package_ndc
71334-215-50
package_description
4 BLISTER PACK in 1 CARTON (71334-215-50) / 14 TABLET, FILM COATED in 1 BLISTER PACK (71334-215-14)
unii
2WTV10SIKH
spl_set_id
4ccee896-e313-4c6c-9674-b4746ada0a90
pharm_class_epc
Pyruvate Kinase Activator [EPC]
active_ingredient_name
MITAPIVAT
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class